CD99 and Ewing sarcoma: In detail, the group observed that metastatic patients with low β3-ARs levels in circulating CD99+ cells had a complete remission in the two years of the study, while metastatic ones, with higher β3-ARs in CD99+ cells, had relapsed within the study, indicating thus a possible role of β3-ARs in the ES progression.